Allspring Global Investments Holdings, LLC
Position in NKTR — Nektar Therapeutics
CIK 1890906
CHARLOTTE, NC
Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$208,801
+$290 QoQ
Shares Held
2,991
+3.2% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#185
of 239 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 33%
Shared 0%
None 67%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $767,651,533 across 75 Biotechnology names. NKTR ranks #69 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
170,829 | $158,490,019 | |
| 2 | EXEL |
Exelixis, Inc.
|
1,998,471 | $108,736,806 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
140,631 | $69,855,635 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
742,547 | $55,304,900 | |
| 5 | ASND |
Ascendis Pharma A/S
|
178,738 | $47,672,997 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
523,192 | $45,491,543 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,700 | $43,460,737 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
67,668 | $36,334,331 |
All Filings in NKTR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,801 | 2,991 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $208,511 | 2,898 | Shares | Defined | 2026-05-05 | |
| 2022-12-31 | $426,843 | 188,869 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $424,275 | 132,586 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $538,878 | 141,810 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $706,149 | 131,011 | Shares | Defined | 2022-05-02 | |
| 2021-12-31 | $682,727 | 50,535 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||